Similarly, SLC2A1 elevated mRNA levels were observed in a smaller, independent breast cancer patient-derived xenograft (PDX) cohort from the Princess Margaret Cancer Center (PM-PDXs) (Fig. 1c. The gene discussed is SLC2A1; the disease is breast cancer.